NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 263 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,358,659 | +27.7% | 146,047 | +228.2% | 0.01% | -14.3% |
Q2 2023 | $1,846,750 | +42.8% | 44,500 | +107.0% | 0.01% | -63.2% |
Q1 2023 | $1,293,010 | +102.4% | 21,500 | +146.9% | 0.02% | +58.3% |
Q4 2022 | $638,732 | -35.8% | 8,708 | -33.5% | 0.01% | -36.8% |
Q3 2022 | $995,000 | +380.7% | 13,100 | +340.8% | 0.02% | +216.7% |
Q2 2022 | $207,000 | -12.7% | 2,972 | +39.7% | 0.01% | -76.9% |
Q3 2020 | $237,000 | -84.0% | 2,128 | -89.3% | 0.03% | -70.8% |
Q3 2019 | $1,481,000 | +12.5% | 19,804 | -4.9% | 0.09% | -38.6% |
Q2 2019 | $1,317,000 | +24.8% | 20,833 | -4.9% | 0.14% | -16.7% |
Q1 2019 | $1,055,000 | – | 21,910 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |